SACRAMENTO, CA – April 3, 2025 – A Safe Choice Network today announced the expansion of its telehealth services providing access to mifepristone, a medication used for early pregnancy termination. This groundbreaking service connects patients with board-certified healthcare providers through secure virtual consultations and delivers FDA-approved medications directly to patients’ homes.
“Access to reproductive healthcare shouldn’t depend on geographic location or transportation barriers,” according to a statement from A Safe Choice Network. “Our telehealth platform removes these obstacles while maintaining the highest standards of medical care and patient privacy.”
The service addresses critical gaps in reproductive healthcare access across the country. Patients who previously faced challenges such as long travel distances, time away from work or family, or privacy concerns can now receive care through secure video consultations from the comfort of their homes.
A Safe Choice Network’s telehealth platform offers comprehensive care throughout the medication abortion process. After an initial virtual consultation to determine medical eligibility, patients can receive mifepristone and accompanying medications through discreet, unmarked packaging delivered directly to their specified address. The organization’s healthcare providers remain available during business hours to answer questions and provide guidance, with scheduled follow-up appointments ensuring procedure completion and addressing any ongoing concerns.
“We’ve developed this service with patient needs at the forefront,” the organization explained in its announcement. “Our platform combines medical expertise with technological innovation to provide safe, accessible reproductive healthcare options for those who need them.”
The telehealth service utilizes state-of-the-art security protocols to protect patient information and ensure complete confidentiality. All communications occur through encrypted channels, and medication packaging contains no identifying information about the contents or provider.
Clinical research consistently demonstrates that medication abortion with mifepristone is both safe and effective, with success rates between 95-99% for pregnancies up to 10 weeks gestation. Serious complications are rare, occurring in fewer than 0.5% of patients—a safety profile exceeding many common over-the-counter medications.
A Safe Choice Network’s commitment to accessibility extends to financial considerations as well. The organization offers transparent pricing information and sliding scale fees based on financial need. Staff members work with patients to verify insurance coverage and connect them with additional resources when applicable.
The organization further stated, “Everyone deserves access to essential healthcare services regardless of their economic status or geographic location. Our telehealth model represents a significant step forward in making reproductive healthcare truly accessible to all.”
Individuals interested in learning more about A Safe Choice Network’s telehealth mifepristone services can visit their website to schedule a confidential consultation or explore educational resources about medication abortion options.
About A Safe Choice Network
A Safe Choice Network is a leading provider of comprehensive reproductive healthcare services based in Sacramento, California. The organization is committed to expanding access to safe, confidential care through innovative healthcare delivery models. Their team of board-certified providers specializes in reproductive health and remains dedicated to patient-centered care that respects individual needs and circumstances.
This press release contains information about mifepristone for educational purposes only. Individuals seeking personalized medical advice should consult with qualified healthcare providers.